ClinicalTrials.Veeva

Menu
H

Homestead Associates In Research | Homestead, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-6024
SEL-212
Semaglutide
Teriflunomide
RO7790121
Apalutamide
Remibrutinib
MTX
JNJ-53718678
Inebilizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 23 total trials

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Researchers are looking for ways to treat a type of liver disease caused by elevated liver fat, called metabolic dysfunction-associated steatohepatit...

Enrolling
Metabolic Dysfunction-associated Steatotic Liver Disease
Non-alcoholic Fatty Liver Disease
Combination Product: Efinopegdutide
Combination Product: Placebo

The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythemat...

Begins enrollment this month
Active Refractory Rheumatoid Arthritis
Systemic Lupus Erythematosus
Drug: Blinatumomab
Drug: Inebilizumab

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-...

Enrolling
COVID-19
Biological: CVXGA (CVXGA50)
Biological: COMIRNATY®

The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.

Active, not recruiting
Crohn's Disease
Biological: JNJ-78934804
Biological: Golimumab

This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of RO7790121 compared with p...

Enrolling
Moderately to Severely Active Ulcerative Colitis
Drug: Placebo
Drug: RO7790121

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with mod...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: KarXT

This study will evaluate the safety and efficacy of empasiprubart compared with placebo in adult participants with dermatomyositis (DM).The study dur...

Enrolling
Myositis
Dermatomyositis
Other: Placebo IV
Biological: Empasiprubart IV

The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus peglot...

Active, not recruiting
Gout
Drug: Methotrexate
Biological: Pegloticase

This study will evaluate the effect of efinopegdutide administration once every 2 weeks (Q2W) versus once weekly (Q1W) on mean relative reduction fro...

Active, not recruiting
Nonalcoholic Fatty Liver Disease
Metabolic Dysfunction-Associated Steatotic Liver Disease
Drug: Efinopegdutide

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

Enrolling
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Remibrutinib

Trial sponsors

Amgen logo
Janssen (J&J Innovative Medicine) logo
G
Merck Sharp & Dohme (MSD) logo
Boehringer Ingelheim logo
C
Karuna Therapeutics logo
M
M
Novartis logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems